INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer
Cancer Trials Ireland
Cancer Trials Ireland
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
University of Washington
Hoffmann-La Roche
AstraZeneca
M.D. Anderson Cancer Center
Proton Collaborative Group
NYU Langone Health